Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
07/2003
07/30/2003EP1330458A1 N-( 1,2,4]triazoloazinyl) thiophenesulfonamide compounds as herbicides
07/30/2003EP1330448A2 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders
07/30/2003EP1330233A1 Method of treating stroke
07/30/2003CN1433411A Chemical compounds
07/30/2003CN1433396A Pharmaceutical compounds
07/30/2003CN1432873A Acid generating agent, sulfonic acid, sulfonic acid and radiation-sensitive resin composition
07/30/2003CN1432562A Intermediate product for preparing benzamidoxime derivative
07/30/2003CN1116294C Synthesis of 3-carbomethoxy-4,5-dimethylthiophene
07/30/2003CN1116277C Process for preparing carbocylic or heterocyclic nitriles by vapor phase ammoxidation
07/30/2003CN1116271C Method of producing 2-substituted-3,4-fused heterocycle benzoic acid
07/29/2003US6600058 Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments
07/29/2003US6600052 With a ring cyclizing reagent to form the compound of Formula V to yield a compound of Formula V: inhibitors of the cyclooxygenase- II enzyme. and antiinflammatory agents and analgesic pharmaceutical agents.
07/29/2003US6599943 Preventive treatment, related to the radical generating nature of the xanthine dehydrogenase/xanthine oxidase
07/29/2003US6599934 3,4-diaryl thiopenes and analogs thereof having use as antiinflammatory agents
07/29/2003US6599932 Highly selective in killing tumor cells but not normal cells
07/29/2003US6599904 Sulphonamide derivatives, process for their preparation, and their use as medicaments
07/29/2003US6599648 Heterarylbenzene compounds
07/29/2003CA2123514C Novel benzothiophene derivative
07/24/2003WO2003059900A1 Coumarin derivatives, process for their production and use thereof
07/24/2003WO2003059880A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
07/24/2003WO2003059874A2 Aromatic thioether liver x-receptor modulators
07/24/2003WO2003059335A1 Phenyl sulfoxides and phenyl sulfones
07/24/2003WO2003059258A2 Compositions and methods for treating heart failure
07/24/2003WO2003059064A1 Insecticides containing hydrazone derivatives as the active ingredient and novel hydrazone derivatives
07/24/2003WO2003046200A3 Methods for ligand discovery
07/24/2003US20030139475 Novel tricyclic compounds and drug compositions containing same
07/24/2003US20030139457 Small organic molecule regulators of cell proliferation
07/24/2003US20030139453 Difluorobutyric acid metalloprotease inhibitors
07/24/2003US20030139421 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
07/24/2003US20030139405 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
07/24/2003US20030139404 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
07/24/2003US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders
07/24/2003US20030139379 Autoimmune disease, osteoporosis, rheumatic diseases, skin disorders
07/24/2003US20030137240 Di(het)arylaminothiophene derivatives
07/24/2003CA2473374A1 Phenyl sulfoxides and phenyl sulfones
07/24/2003CA2472419A1 Coumarin derivatives, process for their production and use thereof
07/24/2003CA2471311A1 Aromatic thioether liver x-receptor modulators
07/23/2003EP1328521A2 A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride
07/23/2003EP1328508A2 Propionic acid derivatives with ppar-alpha activating properties
07/23/2003EP1025083B1 Process for stereoselective synthesis of prostacyclin derivatives
07/23/2003CN1431941A 挤压模 Extrusion die
07/23/2003CN1431208A Process for prepn. of 5-hydroxybenz [b] thiofuran-3-carboxylic acid derivative
07/22/2003US6596873 2-and 2,5-substituted phenylketoenols
07/22/2003US6596863 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis
07/22/2003US6596756 Treatment of fibromyalgia
07/22/2003US6596754 Preventives/remedies for multiple organ failure
07/22/2003US6596752 Inhibitors of α4β1 mediated cell adhesion
07/22/2003US6596743 Carbamic acid derivatives
07/22/2003US6596741 Compounds of formula I exhibit activity as serotonin, norepinephrine, and dopamine reuptake inhibitors and can be used in the treatment of central nervous system and other disorders.
07/22/2003US6596716 2-propane-sulphonamide derivatives
07/22/2003CA2245250C Benzofuran-acrylic acid derivatives and their use as modulators of rxrs or rars receptors
07/17/2003WO2003057661A1 Prodrugs of excitatory amino acids
07/17/2003WO2003057254A1 Preventives/remedies for urinary disturbance
07/17/2003WO2003057225A2 Phosphate transport inhibitors
07/17/2003WO2003057169A2 4-dedimethylamino tetracycline compounds
07/17/2003WO2003029188A3 Beta-substituted nitrostyrene and cyanostyrene compounds and their use as nematicides and fungicides
07/17/2003US20030135053 For use in human or veterinary conditions, that may be dermatological, rheumatic, respiratory, or cardiovascular and may be used in cosmetics
07/17/2003US20030135045 Glycoprotein IIb/IIIa antagonists
07/17/2003US20030135021 Optically active polythiophenes
07/17/2003US20030134880 Novel cd23 inhibitors
07/17/2003US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus
07/17/2003US20030134227 New photoacid generator compounds ("PAGs") are provided and photoresist compositions that comprise such compounds. In particular, cyclic sulfonium and sulfoxonium PAGs are provided. PAGs of the invention are particularly useful as
07/17/2003US20030131422 Primary intermediates for oxidative coloration of hair
07/17/2003CA2471760A1 Preventives/remedies for urinary disturbance
07/16/2003EP1327636A2 Heterocyclic metallocenes and polymerisation catalysts
07/16/2003EP1327630A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
07/16/2003EP1326993A2 PRODUCTION OF g(a)-HYDROXY-CARBOXYLIC ACIDS USING A COUPLED ENZYME SYSTEM
07/16/2003EP1326827A2 Insecticidal 1,8-naphthalenedicarboxamides
07/16/2003EP1326824A1 Pharmaceutical compounds
07/16/2003CN1430603A Novel bicyclic compounds
07/16/2003CN1430596A New gamma selective retinoids
07/16/2003CN1114602C Ketone derivatives and medicinal use thereof
07/15/2003US6593493 2-(Carboxy(unsaturated)alkyl)-1-(haloalkoxy)benzene derivatives; retinoid X receptors; cardiovascular, skin, eating and vision disorders; anticarcinogenic agents; non-insulin-dependent diabetes
07/15/2003US6593374 Such as 3-(3'4'5'-trimethoxybenzoyl)-2-(3'benzylphosphate 4'methoxyphenyl)-6-methoxybenzo(b)thiophene; functionalized to prepare phosphate esters, phosphate salts, and phosphoramidates useful as antitumor agents
07/15/2003US6593359 Use of a RAR-γ-specific agonist ligand for increasing the rate of apoptosis
07/15/2003US6593352 2-phenylalkylaminobenzoic acid containing substituted benzylsufamoyl group; useful for treating cardiovascular disorders, and for preserving or storing a transplant for surgery
07/15/2003US6593327 Compounds and compositions as protease inhibitors
07/15/2003US6592631 Useful as developer compounds in oxidation dye compositions for keratin fibers.
07/15/2003CA2238465C Triaromatic compounds, compositions containing them and uses
07/15/2003CA2218766C Bicyclic-aromatic compounds
07/10/2003WO2003055850A1 β-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS
07/10/2003WO2003055848A2 Urea derivatives as vr1- antagonists
07/10/2003WO2003055847A1 Carboxylic acid derivative
07/10/2003WO2003055484A1 Urea derivatives
07/10/2003WO2003055479A1 Compounds and their therapeutic use related to the phosphorylating activity of the enzyme gsk-3
07/10/2003WO2003055478A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
07/10/2003WO2003010140A3 Hepatitis c virus polymerase inhibitors with heterobicyclic structure
07/10/2003WO2001098248A3 Hiv integrase inhibitors
07/10/2003WO2001096297A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
07/10/2003US20030130515 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
07/10/2003US20030130511 Replacing a halogen atom with an electrophilic group (e.g., a formyl group) using either a mixture of an organomagnesium halide and an alkyllithium or a reaction product of the two, such as trialkylmagnesium lithium
07/10/2003US20030130456 Vinyl group-containing diarylethene and polymer thereof having excellent optical properties
07/10/2003US20030130349 Inhibitors of alpha 4beta1 mediated cell adhesion
07/10/2003US20030130345 C2-substituted idan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals
07/10/2003US20030130342 Such as anticoagulant 3-(6-(4-(aminoiminomethyl)phenyl methoxy)-2-methyl-2H-1-benzopyran-2-yl)propanoic acid hydrochloride
07/10/2003US20030130339 Such as (E)-2-pyridineethenyl-4-fluorobenzyl sulfone; antitumor/anticancer agents
07/10/2003US20030130287 Psychological disorders; central nervous system disorders; antidepressants; Parkinson's disease; Alzheimer's disease;cardiovascular disorders
07/10/2003US20030130279 Hyperglycemic agents; dietetics; cardiovascular disorders; immunology modulation; osteoporosis; cognition activators
07/10/2003US20030130258 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/10/2003US20030130239 Vision defects